Central pontine myelinolysis risk factors: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(6 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Central pontine myelinolysis}}
{{Central pontine myelinolysis}}
{{CMG}}
 
{{CMG}}; {{AE}} {{MMJ}}
==Overview==
==Overview==
The most potent risk factor in the development of central pontine myelinolysis is [[hyponatremia]]. Other risk factors include: Liver dysfunction and [[liver diseases]], [[hypocholesterolemia]], [[alcoholism]], [[malnutrition]], systemic medical disease and [[hemodialysis]].
==Risk Factors==
==Risk Factors==
It has been postulated that one underlying cause may be the lack of a substance that is essential for brain activity and is lacking due to [[malnutrition]]. The fact that this condition is most frequently observed in patients with general ill health ([[alcoholism]], [[cachexia]] etc.) is in accordance with this hypothesis. <ref>Adams RA, Victor M, Mancall EL. Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholics and malnourished patients. ''Arch Neurol Psychiatry.'' 1959;81:154–72PMID 13616772</ref>
===Common Risk Factors===
*The most potent risk factor in the development of central pontine myelinolysis is [[hyponatremia]].
*Other risk factors include:<ref name="pmid19797900">{{cite journal| author=Lee EM, Kang JK, Yun SC, Kim KH, Kim SJ, Hwang KS et al.| title=Risk factors for central pontine and extrapontine myelinolysis following orthotopic liver transplantation. | journal=Eur Neurol | year= 2009 | volume= 62 | issue= 6 | pages= 362-8 | pmid=19797900 | doi=10.1159/000242426 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19797900  }} </ref><ref name="pmid24716023">{{cite journal| author=Jacob S, Gupta H, Nikolic D, Gundogdu B, Ong S| title=Central pontine and extrapontine myelinolysis: the great masquerader-an autopsy case report. | journal=Case Rep Neurol Med | year= 2014 | volume= 2014 | issue=  | pages= 745347 | pmid=24716023 | doi=10.1155/2014/745347 | pmc=3970353 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24716023  }} </ref><ref name="pmid15316041">{{cite journal| author=Martin RJ| title=Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes. | journal=J Neurol Neurosurg Psychiatry | year= 2004 | volume= 75 Suppl 3 | issue=  | pages= iii22-8 | pmid=15316041 | doi=10.1136/jnnp.2004.045906 | pmc=1765665 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15316041  }} </ref><ref name="pmid12535304">{{cite journal| author=Oo TN, Smith CL, Swan SK| title=Does uremia protect against the demyelination associated with correction of hyponatremia during hemodialysis? A case report and literature review. | journal=Semin Dial | year= 2003 | volume= 16 | issue= 1 | pages= 68-71 | pmid=12535304 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12535304 }} </ref>
**[[Liver dysfunction]] and [[liver diseases]]
**[[Hypocholesterolemia]]
**[[Alcoholism]]
**[[Malnutrition]]
**Systemic medical disease
**[[Hemodialysis]]
 
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}


[[Category:Disease]]
{{WH}}
[[Category:Neurology]]
{{WS}}
[[Category:Intensive care medicine]]
[[Category: (name of the system)]]
[[Category:Nephrology]]
[[Category:Emergency medicine]]
 
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 03:56, 15 August 2019

Central pontine myelinolysis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Central pontine myelinolysis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Central pontine myelinolysis risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Central pontine myelinolysis risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Central pontine myelinolysis risk factors

CDC on Central pontine myelinolysis risk factors

Central pontine myelinolysis risk factors in the news

Blogs on Central pontine myelinolysis risk factors

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Central pontine myelinolysis risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]

Overview

The most potent risk factor in the development of central pontine myelinolysis is hyponatremia. Other risk factors include: Liver dysfunction and liver diseases, hypocholesterolemia, alcoholism, malnutrition, systemic medical disease and hemodialysis.

Risk Factors

Common Risk Factors

References

  1. Lee EM, Kang JK, Yun SC, Kim KH, Kim SJ, Hwang KS; et al. (2009). "Risk factors for central pontine and extrapontine myelinolysis following orthotopic liver transplantation". Eur Neurol. 62 (6): 362–8. doi:10.1159/000242426. PMID 19797900.
  2. Jacob S, Gupta H, Nikolic D, Gundogdu B, Ong S (2014). "Central pontine and extrapontine myelinolysis: the great masquerader-an autopsy case report". Case Rep Neurol Med. 2014: 745347. doi:10.1155/2014/745347. PMC 3970353. PMID 24716023.
  3. Martin RJ (2004). "Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes". J Neurol Neurosurg Psychiatry. 75 Suppl 3: iii22–8. doi:10.1136/jnnp.2004.045906. PMC 1765665. PMID 15316041.
  4. Oo TN, Smith CL, Swan SK (2003). "Does uremia protect against the demyelination associated with correction of hyponatremia during hemodialysis? A case report and literature review". Semin Dial. 16 (1): 68–71. PMID 12535304.

Template:WH Template:WS